"One of the most complex aspects of planning for a clinical trial is gauging how much commercial drug will be required over the duration of the study, and that's a core competency for Avayle," said Morse, who brings more than 25 years of experience to the Company. "We have developed AvayleForecast, a proprietary tool that allows clients to monitor and accurately forecast consumption and stay up-to-date on trends and supply changes.
"As part of the planning process, clients frequently need to anticipate a range of scenarios, such as an increase in the number of patients, an expansion of trial sites or a change to the dosing regimen," Morse explained. "By providing accurate forecasts with actionable data to support and enhance trial planning across multiple 'what-if' scenarios, Avayle is able to de-risk the supply chain and add significant value to the procurement process."
"As the number of active comparator trials increases around the world, so do the regulatory requirements associated with those studies," said Bishop, who has more than 20 years of pharmaceutical industry experience. "We offer clients a simplified and streamlined procurement process, dedicated project management and cost-effective solutions scaled to the size of their trial. Another important differentiator for Avayle is that our European operations are headquartered in
Bishop received a Master of Business Administration from the
Morse received a Bachelor of Interdisciplinary Studies in Leadership Studies from
Learn more by visiting www.avaylects.com or calling (215) 692.7134. View source version on businesswire.com: https://www.businesswire.com/news/home/20180917005366/en/
Keywords for this news article include: Avayle CTS,
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC